Bandingkan Harga & Kinerja UBC Medical Indonesia Tbk. (LABS) vs Sarana Meditama Metropolitan Tbk. (SAME)

UBC Medical Indonesia Tbk.Trading

Sarana Meditama Metropolitan Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan UBC Medical Indonesia Tbk. dan Sarana Meditama Metropolitan Tbk.: UBC Medical Indonesia Tbk. diperdagangkan di Rp174 (kapitalisasi pasar 691,25 M, volume 24 jam 635,5 rb), sedangkan Sarana Meditama Metropolitan Tbk. diperdagangkan di Rp304 (kapitalisasi pasar 5,22 T, volume 24 jam 900,6 rb). Perbedaan utamanya: Sarana Meditama Metropolitan Tbk. jauh lebih besar — sekitar 7,6× kapitalisasi pasar UBC Medical Indonesia Tbk., dan Sarana Meditama Metropolitan Tbk. lebih aktif diperdagangkan (900,6 rb vs 635,5 rb). Mana yang lebih baik tergantung tujuan investasimu.

	LABS	SAME
Kapitalisasi Pasar	691,25 M	5,22 T
Volume	635,5 rb	900,6 rb
Lot	6,36 rb	9,01 rb
Perputaran	110,15 jt	273,71 jt
Harga Rata-rata	173,33	303,92
Nilai Transaksi	110,15 jt	273,71 jt
Harga Ekuilibrium Indikatif	174	302
Volume Ekuilibrium Indikatif	50	2

Lihat detail →Lihat detail →

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

LABS

Lihat detail →

SAME

Lihat detail →

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS →